Skip to main content

The independent medical news service

28-11-2022 | Oncology | News | Article

Cancer screening uptake fails to return to prepandemic rates

The rates of population-based screening and diagnosis of breast, cervical, and colorectal cancer in the USA in 2021 remained below those reported before the COVID-19 pandemic, researchers caution in JAMA Oncology.

Molecule of DNA forming inside the test tube in the blood test equipment 3d rendering

28-07-2022 | Oncology | News | Article

ctDNA analysis can detect KRAS G12C mutations in people with cancer

A large US study has shown the feasibility of circulating tumor DNA analysis to detect KRAS G12C mutations in patients with solid tumors.

abstract world map

11-07-2022 | Oncology | News | Article

Cancer screening declined globally during COVID-19 pandemic

A systematic review and meta-analysis has identified global decreases in breast, cervical, and colorectal cancer screening during the early phase of the COVID-19 pandemic.

USA outline_flag

12-05-2021 | Oncology | News | Article

COVID-19 leaves large cancer screening deficit in USA

Breast, prostate, and colorectal cancer screening rates declined sharply during the initial months of the COVID-19 pandemic in the USA, and while they subsequently recovered, a large deficit remains, study findings indicate.

13-04-2021 | Oncology | News | Article

Mechanisms of resistance to KRAS G12C inhibition characterized

US researchers have identified diverse molecular and histologic mechanisms of acquired resistance to KRAS G12C inhibitors in people with cancer.

31-03-2021 | Oncology | News | Article

Worse cancer outcomes in areas of deprivation transcend access to quality care

Researchers have identified an association between socioeconomic deprivation and poor survival in people with cancer participating in clinical trials.